Intact and Subunit Protein Analysis Solutions

Intact and Subunit Protein Analysis Solutions

Achieve fast and accurate intact mass and subunit protein analysis solutions for structural confirmation, modifications, and glycoform heterogeneity with Waters technologies.  Elevate your lab’s productivity with useful protein structural insights using compliant-ready hardware and software solutions along with robust columns, specifically QC batch-tested with relevant proteins.

Achieve fast and accurate intact mass and subunit protein analysis solutions for structural confirmation, modifications, and glycoform heterogeneity with Waters technologies.  Elevate your lab’s productivity with useful protein structural insights using compliant-ready hardware and software solutions along with robust columns, specifically QC batch-tested with relevant proteins.


Intact Protein Analysis
Intact Protein Analysis

Overview

Waters workflow solutions deliver quick and accurate intact protein measurement for confirmation of identity, modifications, and glycoform heterogeneity, and include:

  • MaxPeak Premier Solutions to maximize separations performance and consistency with purposefully designed chromatography systems and consumables
  • Xevo G3 QTof and BioAccord System for robust, powerful characterization and monitoring to reliably generate intact mass data and elevate your laboratory’s productivity
  • SYNAPT XS and SELECT SERIES Cyclic IMS to perform in depth protein characterization and differentiate between conformations with flexible fragmentation and ion mobility separation
  • waters_connect informatics for a compliance ready, app- based software platform, enabling easy method sharing, and data management

Streamlined, simplified LC-MS analysis for every laboratory

Applications

Mass spectrometry and light scattering techniques can provide multiple quality attributes of proteins throughout the development and manufacture process. This can be performed at the intact protein or subunit level and may involve identity, characterizing post-translational modifications (such as oxidation, glycosylation and PEGylation), impurity analysis, and oligomer characterization.

Mass spectrometry and light scattering techniques can provide multiple quality attributes of proteins throughout the development and manufacture process. This can be performed at the intact protein or subunit level and may involve identity, characterizing post-translational modifications (such as oxidation, glycosylation and PEGylation), impurity analysis, and oligomer characterization.


Application Notes

Application Notes


Webinar: SEC Column Selection and Care for Biotherapeutic Proteins and Peptides

Size exclusion chromatography (SEC) is commonly used throughout the research, development, and commercialization of biotherapeutic proteins and peptides. The key to successful SEC methods begins with selecting an appropriate SEC column, based on application need and LC instrumentation, and separation method to generate reliable quantitative data. Watch our webinar to learn how to select the right SEC column for your application and separation challenges.

Size exclusion chromatography (SEC) is commonly used throughout the research, development, and commercialization of biotherapeutic proteins and peptides. The key to successful SEC methods begins with selecting an appropriate SEC column, based on application need and LC instrumentation, and separation method to generate reliable quantitative data. Watch our webinar to learn how to select the right SEC column for your application and separation challenges.


Meet the people behind the quality products you use from Waters as they discuss the analytical challenges and opportunities facing scientists involved in established and trending applications.

Solutions


Enhance efficiency and accelerate sample throughput with system solutions tailored to labs conducting intact protein separation and analysis.

Enhance efficiency and accelerate sample throughput with system solutions tailored to labs conducting intact protein separation and analysis.

Routine biopharmaceutical analysis – accessible and accelerated

Routine biopharmaceutical analysis – accessible and accelerated

Achieve rapid and confident decisions driven by accessible, high-quality data with the BioAccord LC-MS System with ACQUITY Premier that is specifically designed for routine monitoring in biopharmaceutical process and product development.

  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability

Complete coverage for confident characterization

Complete coverage for confident characterization

Maximize sample information for your analytes from detailed characterization to accurate quantitation with the Xevo G3 QTof, which enables complete confidence in your results – from challenging small molecules to complex biotherapeutics.

  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability

Ultimate flexibility for deeper discovery

Ultimate flexibility for deeper discovery

Unlike competitor systems with restricted inlet options, scan function limitations, or requiring multiple platforms, only Waters offers an all-encompassing high-performing LC-MS solution, the SYNAPT XS mass spectrometer, for ultimate flexibility and greater freedom of analytical choice – supporting scientific creativity and technical success for any application.

  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability

Endless possibilities, limitless research

Endless possibilities, limitless research

Developed through focused collaboration, the SELECT SERIES Cyclic IMS combines novel cyclic ion mobility separation with state-of-the-art, high performance, time-of-flight mass spectrometry, enabling leading researchers to unlock the potential in scientific discovery.

  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability

The universal platform for liquid chromatography

The universal platform for liquid chromatography

Eliminate the unpredictability of analyte losses due to metal interactions with MaxPeak Premier Solutions that combine state-of-the-art column and system technology for maximum sensitivity and reproducibility.

  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability
  • Real-Time Process Monitoring
  • Candidate Screening

Uniquely versatile detector for every development stage

Uniquely versatile detector for every development stage

Place downstream of any LC and perform advanced analysis of protein-complexes, post-translational modifications, and aggregation with the DAWN MALS Detector that assists at every development stage. Couple with Eclipe to measure binding affinity during discovery.

  • Candidate Screening
  • Chromatography
  • Identity and Post-Translational Modification Analysis
  • Aggregation and Stability

Measure size and zeta potential in native buffer

Measure size and zeta potential in native buffer

Combine DLS, SLS, and ELS all in one platform with the DynaPro ZetaStar instrument, specifically designed for biopharma to measure zeta-potential in formulation buffer without dilution.

  • Aggregation and Stability
  • Chromatography

High-throughput size and stability screening

High-throughput size and stability screening

Measure size, polydispersity, and Tagg data for hundreds of samples with as little as 4 µL per well with the DynaPro DLS Plate Reader that uses standard-well plates and can integrate with any liquid handler to boost productivity further.

  • Candidate Screening
  • Aggregation and Stability

A process analytical technology breakthrough for nanoparticles, biopharmaceuticals, and polymers

A process analytical technology breakthrough for nanoparticles, biopharmaceuticals, and polymers

Directly monitor titer, size, and impurities in real-time with ultraDAWN Multi-angle Light Scattering Detector that seamlessly connects downstream purification and enrichment methods, such as IEX, FPLC, or TFF.

  • Real-Time Process Monitoring


The data speaks for itself

The data speaks for itself
Using the UPLC Intact Mass Analysis Kit, rapid gradient cycles were applied to regenerate the column to pre-injection conditions as part of the analysis of an intact antibodAnalysis of NISTmAb reference material 8671 on the XBridge Premier Protein SEC 250 Å and the competitive silica dSEC-2 column Isocratic separation performed using a mobile phase of 2x PBS in water, flow rate of 0.57 mL/min, and UV detection at 280 nm. Analysis of NISTmAb reference material 8671 on the XBridge Premier Protein SEC 250 Å and the competitive silica dSEC-2 column Isocratic separation performed using a mobile phase of 2x PBS in water, flow rate of 0.57 mL/min, and UV detection at 280 nm.
Using the UPLC Intact Mass Analysis Kit, rapid gradient cycles were applied to regenerate the column to pre-injection conditions as part of the analysis of an intact antibody. The total ion chromatogram (TIC) shows no detectable carryover following a 0.5 ug injection. Thus, the need to use inter-run blank injections with difficult samples is eliminated. Using the UPLC Intact Mass Analysis Kit, rapid gradient cycles were applied to regenerate the column to pre-injection conditions as part of the analysis of an intact antibody. The total ion chromatogram (TIC) shows no detectable carryover following a 0.5 µg injection. Thus, the need to use inter-run blank injections with difficult samples is eliminated. 
Peptide mapping analysis of trastuzumab fractions. (A) Trastuzumab fractions collected from a BioResolve SCX mAb, 4.6 × 100 mm Column. (B) Mirror image of peptide maps for Fractions 5 and 7. A peak at a retention time of 30.24 min increased significantly in Fraction 5, compared to that in Fraction 7 (indicated by the blue arrow). (C) Extracted ion chromatograms (XIC) for identified peptides. The peak at 30.26 min has been identified as deamidation of the peptide ASQDVNTAVAWYQQKPGK. The un-modified peak has a retention time of 29.63 min. (D) MS-MS fragment comparison of the deamidated and un-modified peptide ASQDVNTAVAWYQQKPGK. The fragments that do not contain asparagine have the same mass value, while the fragments that do contain asparagine differ in 1 Da in mass Peptide mapping analysis of trastuzumab fractions. (A) Trastuzumab fractions collected from a BioResolve SCX mAb, 4.6 × 100 mm Column. (B) Mirror image of peptide maps for Fractions 5 and 7. A peak at a retention time of 30.24 min increased significantly in Fraction 5, compared to that in Fraction 7 (indicated by the blue arrow). (C) Extracted ion chromatograms (XIC) for identified peptides. The peak at 30.26 min has been identified as deamidation of the peptide ASQDVNTAVAWYQQKPGK. The un-modified peak has a retention time of 29.63 min. (D) MS-MS fragment comparison of the deamidated and un-modified peptide ASQDVNTAVAWYQQKPGK. The fragments that do not contain asparagine have the same mass value, while the fragments that do contain asparagine differ in 1 Da in mass.
Combined MS spectra, zoom, and corresponding MaxEnt1 deconvoluted masses of trastuzumab using different IDC counts Combined MS spectra, zoom, and corresponding MaxEnt1 deconvoluted masses of trastuzumab using different IDC counts.
Separation of mAb Subunit Standard using 1-minute and 4-minute gradient on a 20 mm column, as well as 20-min gradient on a 100 mm column. Comparable combined spectra of the three main peaks and the deconvoluted mass (insert) were obtained Separation of mAb Subunit Standard using 1-minute and 4-minute gradient on a 20 mm column, as well as 20-min gradient on a 100 mm column. Comparable combined spectra of the three main peaks and the deconvoluted mass (insert) were obtained.
Comparison of LC-MS separation of the mAb Subunit Standard on a 2.1 x 20 mm BioResolve Premier RP mAb Polyphenyl 450 Å 2.7 µm Column (4-minute gradient) and a 2.1 x 100 mm BioResolve RP mAb Polyphenyl 450 Å 2.7 µm Column (20-minute gradient). Comparison of LC-MS separation of the mAb Subunit Standard on a 2.1 x 20 mm BioResolve Premier RP mAb Polyphenyl 450 Å 2.7 µm Column (4-minute gradient) and a 2.1 x 100 mm BioResolve RP mAb Polyphenyl 450 Å 2.7 µm Column (20-minute gradient).

Webinars and Resources



  • Application Notebook

A Focus on Protein Therapeutics

A Focus on Protein Therapeutics
  • eBook

Improving Chromatographic Separations of Biopharmaceuticals with MaxPeak High Performance Surfaces (HPS) Technology

Improving Chromatographic Separations of Biopharmaceuticals with MaxPeak High Performance Surfaces (HPS) Technology

Related

Support patient safety with Host Cell Protein (HCP) assays to meet regulatory requirements and minimize the risk of immunogenic responses with Waters solutions for biotherapeutic analysis.

Ensure drug development and quality standards are met with Waters leading solutions for lab-scale synthetic peptides like glucagon-like peptide 1(GLP-1) purification, characterization, and monitoring.

Learn more about Intact and Subunit Protein Analysis Solutions.

Learn more about Intact and Subunit Protein Analysis Solutions.

Intact Protein Analysis